Anti-LZTS2 antibodies are used in the immunodetection of the protein leucine zipper tumor suppressor 2. In humans, the canonical protein has a reported length of 669 amino acid residues and a mass of 72.8 kDa. Its subcellular localization is in the cytoplasm. It is reported to be highly expressed in prostate and testis, and at slightly lower levels in spleen, thymus, uterus, small intestine and colon. A member of the LZTS2 protein family, LZTS2 is a reported regulator of katanin-mediated microtubule severing and release from the centrosome. Synonyms for this target antigen include leucine zipper, putative tumor suppressor 2, protein LAPSER1, and leucine zipper putative tumor suppressor 2. LZTS2 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Some LZTS2 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.